AbbVie expects $2.7 billion R&D charge in third quarter, lowers annual profit forecast – Reuters
- AbbVie expects $2.7 billion R&D charge in third quarter, lowers annual profit forecast Reuters
- AbbVie to Host Third-Quarter 2025 Earnings Conference Call Yahoo Finance
- AbbVie expects $2.7 billion R&D charge in third quarter By Reuters Investing.com
- AbbVie sees $1.50 per share unfavorable impact in Q3 from milestones expense TipRanks
- AbbVie Says $2.7 Billion in Costs Seen Cutting Q3 EPS by $1.50 MarketScreener